Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bluejay Diagnostics, Inc.BJDX · Entity 8627 | Chief Financial Officer | March 17, 2022 | March 21, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bluejay Diagnostics, Inc.
Report date March 17, 2022 · Filed March 21, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 18,500 |
Reported balance
After 2022-03-17 transaction · row 1
1 source rowRow 1 · 2022-03-17 · Purchase · Acquired 2,500 · Balance 18,500 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 17, 2022 Filed Mar 21, 2022 15:57 UTC | Bluejay Diagnostics, Inc. BJDX · Entity 8627 | PurchaseCommon Stock | 2,500 | $1.16 | $2,897.50 |
DisclosureSEC source: 0001213900-22-013794 · ownership.xml · nonDerivative · entry 1 Kinder Gordon Winston · CIK 0001889229 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,500 Read SEC document |
| March 16, 2022 Filed Mar 17, 2022 01:54 UTC | Bluejay Diagnostics, Inc. BJDX · Entity 8627 | PurchaseCommon Stock | 5,000 | $1.02 | $5,100.00 |
DisclosureSEC source: 0001213900-22-013084 · ownership.xml · nonDerivative · entry 3 Kinder Gordon Winston · CIK 0001889229 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 F2 · price: This transaction was executed in multiple trades at prices ranging from $1.01 to $1.04. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 01:54 UTC | Bluejay Diagnostics, Inc. BJDX · Entity 8627 | PurchaseCommon Stock | 500 | $0.91 | $455.00 |
DisclosureSEC source: 0001213900-22-013084 · ownership.xml · nonDerivative · entry 2 Kinder Gordon Winston · CIK 0001889229 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Read SEC document |
| March 14, 2022 Filed Mar 17, 2022 01:54 UTC | Bluejay Diagnostics, Inc. BJDX · Entity 8627 | PurchaseCommon Stock | 10,500 | $0.95 | $9,975.00 |
DisclosureSEC source: 0001213900-22-013084 · ownership.xml · nonDerivative · entry 1 Kinder Gordon Winston · CIK 0001889229 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,500 F1 · price: This transaction was executed in multiple trades at prices ranging from $0.90 to $0.95. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 00:50 UTC | Bluejay Diagnostics, Inc. BJDX · Entity 8627 | GrantOption to purchase common stock · Derivative | 8,066 | Not disclosed Strike: $1.09 | Not disclosed |
DisclosureSEC source: 0001213900-22-009863 · ownership.xml · derivative · entry 1 Kinder Gordon Winston · CIK 0001889229 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,066 Underlying: Common Stock · 8,066 shares Expires 2032-02-25 F2 · price: The stock options were issued in connection with the reporting person's employment services to the Company pursuant to the employment agreement between the reporting person and the Company dated July 1, 2021. F1 · derivative.exercise_date: The stock options set forth in this table vest in three equal annual installments, subject to the grantee's continued service to the Company on each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.